ImportRefusal LogoImportRefusal

ICODI CO., LTD.

⚠️ Moderate Risk

FEI: 3012187418 • Buk-gu, Gwangju Gwangyeogsi • SOUTH KOREA

FEI

FEI Number

3012187418

📍

Location

Buk-gu, Gwangju Gwangyeogsi

🇰🇷
🏢

Address

2 Cheomdan Venture-ro 60 Beon-Gil, , Buk-gu, Gwangju Gwangyeogsi, South Korea

Moderate Risk

FDA Import Risk Assessment

38.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
6
Unique Violations
2/8/2023
Latest Refusal
4/15/2016
Earliest Refusal

Score Breakdown

Violation Severity
59.2×40%
Refusal Volume
28.8×30%
Recency
27.0×20%
Frequency
7.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32804×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

2372×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

24801×

RXPERSONAL

The article appears to be a device which requires a prescription from your doctor.

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
2/8/2023
86LPLLENSES, SOFT CONTACT, DAILY WEAR
118NOT LISTED
237NO PMA
3280FRNMFGREG
Division of Southeast Imports (DSEI)
2/8/2023
86LPLLENSES, SOFT CONTACT, DAILY WEAR
118NOT LISTED
237NO PMA
3280FRNMFGREG
Division of Southeast Imports (DSEI)
12/16/2022
86LPLLENSES, SOFT CONTACT, DAILY WEAR
2480RXPERSONAL
Division of Southeast Imports (DSEI)
5/23/2019
86LPLLENSES, SOFT CONTACT, DAILY WEAR
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
4/15/2016
86MVNLENS, CONTACT (DISPOSABLE)
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is ICODI CO., LTD.'s FDA import refusal history?

ICODI CO., LTD. (FEI: 3012187418) has 5 FDA import refusal record(s) in our database, spanning from 4/15/2016 to 2/8/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ICODI CO., LTD.'s FEI number is 3012187418.

What types of violations has ICODI CO., LTD. received?

ICODI CO., LTD. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about ICODI CO., LTD. come from?

All FDA import refusal data for ICODI CO., LTD. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.